GSK agrees UK deal for meningitis shot after Novartis stand-off
March 29, 2015 at 04:42 AM EDT
LONDON, March 29 (Reuters) - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis.
